Cibinqo Interactions
There are 577 drugs known to interact with Cibinqo (abrocitinib), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 265 are major, 264 are moderate, and 48 are minor.
- View all 577 medications that may interact with Cibinqo
- View Cibinqo alcohol/food interactions (1)
- View Cibinqo disease interactions (6)
Most frequently checked interactions
View interaction reports for Cibinqo (abrocitinib) and the medicines listed below.
- acetaminophen
- Adbry (tralokinumab)
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- amitriptyline
- betamethasone topical
- Claritin (loratadine)
- clobetasol topical
- Dupixent (dupilumab)
- Emgality (galcanezumab)
- escitalopram
- Lyrica (pregabalin)
- methotrexate
- Mobic (meloxicam)
- Nurtec ODT (rimegepant)
- Opzelura (ruxolitinib topical)
- pantoprazole
- prednisone
- pregabalin
- Prevacid (lansoprazole)
- rosuvastatin
- Synthroid (levothyroxine)
- tacrolimus topical
- tizanidine
- topiramate
- vilazodone
- Vitamin D3 (cholecalciferol)
- Vivelle-Dot (estradiol)
- Wellbutrin XL (bupropion)
- Zofran (ondansetron)
Cibinqo alcohol/food interactions
There is 1 alcohol/food interaction with Cibinqo (abrocitinib).
Cibinqo disease interactions
There are 6 disease interactions with Cibinqo (abrocitinib) which include:
- cardiovascular disease
- infections
- malignancies
- Abrocitinib -thrombosis
- liver dysfunction
- renal dysfunction
Report options
QR code containing a link to this page
More about Cibinqo (abrocitinib)
- Cibinqo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
